Gilead Sciences Market Cap

Gilead Sciences has a market cap or net worth of 107.54 billion as of March 31, 2025. Its market cap has increased by 45.48% in one year.

Market Cap

107.54B

Enterprise Value

119.65B

Revenue

22.97B

Ranking

n/a

PE Ratio

280.49

Stock Price

109.40

Market Cap Chart

Since January 22, 1992, Gilead Sciences's market cap has increased from 138.73M to 107.54B, an increase of 77,418.90%. That is a compound annual growth rate of 22.19%.

Market Cap History

Date	Market Cap	% Change
Mar 28, 2025	107.54B	16.95%
Dec 31, 2024	91.95B	16.03%
Dec 29, 2023	79.25B	-11.32%
Dec 30, 2022	89.37B	32.86%
Dec 31, 2021	67.26B	25.75%
Dec 31, 2020	53.49B	-13.83%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	177.02B
Shell	169.03B
HSBC Holdings	156.29B
Unilever	114.85B
Rio Tinto Group	81.00B
RELX PLC	71.74B
BP p.l.c.	68.91B
British American Tobacco p.l.c.	68.59B

Market Cap Rankings